{"id":408369,"date":"2021-01-05T08:03:28","date_gmt":"2021-01-05T13:03:28","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408369"},"modified":"2021-01-05T08:03:28","modified_gmt":"2021-01-05T13:03:28","slug":"vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/","title":{"rendered":"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BRIDGEWATER, N.J., Jan.  05, 2021  (GLOBE NEWSWIRE) &#8212; VYNE Therapeutics Inc. (Nasdaq: VYNE) (\u201cVYNE\u201d or the \u201cCompany\u201d) today announced that David Domzalski, Chief Executive Officer, will participate in two panel presentations at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Hsx5whTQisBi9pSRxwrTUFdhncLGUeSYIoSZaVHGG-SuQawzeL0k9LhMS0gEUC5PZjKDmaed1qf9lirlnfPSBD5UqTCiXOAU1hXact6-Y2BrDbOY5uNJUZn4Cd2c_ONBY4_u0tOl80VnhmZVnjvPrR_mO5SL2MfVoi-inpwnPWB1bI8S5nKzRCe6_ftuYI5PRmRSoHP7sAA6l1JdGqVZgA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LifeSci Partners 10th Annual Healthcare Corporate Access Event<\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"text-align: left;vertical-align: middle\">\n            <u>Panel Presentation Details<\/u>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;text-align: left;vertical-align: middle\">Title:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%;text-align: left;vertical-align: middle\">\n            <em>Dermatology Innovation: Addressing Physician and Patient Underserved Needs<\/em>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Day:<\/td>\n<td style=\"text-align: left;vertical-align: middle\">Thursday, January 7<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Time:<\/td>\n<td style=\"text-align: left;vertical-align: middle\">2:00pm Eastern Time<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Registration Link:<\/td>\n<td style=\"text-align: left;vertical-align: middle\">\n            <u><br \/>\n              <a href=\"https:\/\/wsw.com\/webcast\/lifesci\/panel9\/2316951\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/wsw.com\/webcast\/lifesci\/panel9\/2316951<\/a><br \/>\n            <\/u>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: right;vertical-align: middle\">\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Title:<\/td>\n<td style=\"text-align: left;vertical-align: middle\">\n            <em>Executing a Successful Product Launch During a Pandemic<\/em>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Day:<\/td>\n<td style=\"text-align: left;vertical-align: middle\">Friday, January 8<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Time:<\/td>\n<td style=\"text-align: left;vertical-align: middle\">2:00pm Eastern Time<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle\">Registration Link:<\/td>\n<td style=\"text-align: left;vertical-align: middle\">\n            <u><br \/>\n              <a href=\"https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307<\/a><br \/>\n            <\/u>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"left\">The format will be a virtual presentation with the opportunity for Q&amp;A at the conclusion.<\/p>\n<p>\n        <strong>About VYNE Therapeutics Inc.<\/strong><br \/>\n        <br \/>In March 2020, Menlo Therapeutics Inc. (&#8220;Menlo&#8221;) and Foamix Pharmaceuticals Ltd. (\u201cFoamix\u201d) combined to form what is now known as VYNE Therapeutics Inc. VYNE&#8217;s mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond.<\/p>\n<p>With expertise in topical medicine innovation as a springboard, VYNE is working to develop and commercialize a variety of solutions using its proprietary Molecule Stabilizing Technology (MST\u2122), and has received FDA approval for AMZEEQ\u00ae (minocycline) topical foam, 4%, the world\u2019s first topical minocycline, and for ZILXI\u2122 (minocycline) topical foam, 1.5%, the first minocycline product of any kind to be approved by the FDA for adults with the pimples and bumps of rosacea. For more information about our approved products, please see AMZEEQ\u2019s Full Prescribing Information at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JD-DqQLpFb-manRin6GhHSWKnF-RDWoj1dj1ueXx7bsnYkFiJ9pjeN_YC-4JNd6D6g1AwK0u0i8RjcBAIAI7sg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">AMZEEQ.com<\/a> and ZILXI\u2019s Full Prescribing Information at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lnPqrg0kq3NgW6DrVdE7PiVQzcP7kBjFwqsFnRVoc-vxj6WHQhBrJ_PzhJsKeA2xZqsezBrOOHq0y7o73i4UHw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ZILXI.com<\/a>.<\/p>\n<p>For more information about VYNE Therapeutics Inc. or its investigational products, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YMRxz038L1pNSrwjWCnnx3EPhoTfPol-rhhY4YsVZYB3trbcCwxbNly0b6CkNukg8p-kDoboUWl475IplF5uxKpyT_fTD-p-sdL91esq7WusiRvZbbKl4DgEesGgcfI5\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.vynetherapeutics.com\/<\/a> or follow VYNE on Twitter. VYNE may use its website to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor VYNE\u2019s website in addition to following its press releases, filings with the U.S. Securities and Exchange Commission, public conference calls, and webcasts.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Joyce Allaire<br \/>LifeSci Advisors, LLC<br \/>646-889-1200<br \/>jallaire@lifesciadvisors.com<\/p>\n<p>Andrew Saik<br \/>Chief Financial Officer<br \/>VYNE Therapeutics<br \/>908-731-6180<br \/>Andrew.Saik@vynetx.com\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/324ca338-b4a8-483e-a74c-466ef0540467\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRIDGEWATER, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; VYNE Therapeutics Inc. (Nasdaq: VYNE) (\u201cVYNE\u201d or the \u201cCompany\u201d) today announced that David Domzalski, Chief Executive Officer, will participate in two panel presentations at the LifeSci Partners 10th Annual Healthcare Corporate Access Event. Panel Presentation Details Title: Dermatology Innovation: Addressing Physician and Patient Underserved Needs Day: Thursday, January 7 Time: 2:00pm Eastern Time Registration Link: https:\/\/wsw.com\/webcast\/lifesci\/panel9\/2316951 \u00a0 \u00a0 Title: Executing a Successful Product Launch During a Pandemic Day: Friday, January 8 Time: 2:00pm Eastern Time Registration Link: https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307 The format will be a virtual presentation with the opportunity for Q&amp;A at the conclusion. About VYNE Therapeutics Inc. In March 2020, Menlo Therapeutics Inc. (&#8220;Menlo&#8221;) and Foamix Pharmaceuticals Ltd. (\u201cFoamix\u201d) combined to form &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408369","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRIDGEWATER, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; VYNE Therapeutics Inc. (Nasdaq: VYNE) (\u201cVYNE\u201d or the \u201cCompany\u201d) today announced that David Domzalski, Chief Executive Officer, will participate in two panel presentations at the LifeSci Partners 10th Annual Healthcare Corporate Access Event. Panel Presentation Details Title: Dermatology Innovation: Addressing Physician and Patient Underserved Needs Day: Thursday, January 7 Time: 2:00pm Eastern Time Registration Link: https:\/\/wsw.com\/webcast\/lifesci\/panel9\/2316951 \u00a0 \u00a0 Title: Executing a Successful Product Launch During a Pandemic Day: Friday, January 8 Time: 2:00pm Eastern Time Registration Link: https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307 The format will be a virtual presentation with the opportunity for Q&amp;A at the conclusion. About VYNE Therapeutics Inc. In March 2020, Menlo Therapeutics Inc. (&#8220;Menlo&#8221;) and Foamix Pharmaceuticals Ltd. (\u201cFoamix\u201d) combined to form &hellip; Continue reading &quot;VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T13:03:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week\",\"datePublished\":\"2021-01-05T13:03:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/\"},\"wordCount\":351,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/\",\"name\":\"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=\",\"datePublished\":\"2021-01-05T13:03:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/","og_locale":"en_US","og_type":"article","og_title":"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week - Market Newsdesk","og_description":"BRIDGEWATER, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) &#8212; VYNE Therapeutics Inc. (Nasdaq: VYNE) (\u201cVYNE\u201d or the \u201cCompany\u201d) today announced that David Domzalski, Chief Executive Officer, will participate in two panel presentations at the LifeSci Partners 10th Annual Healthcare Corporate Access Event. Panel Presentation Details Title: Dermatology Innovation: Addressing Physician and Patient Underserved Needs Day: Thursday, January 7 Time: 2:00pm Eastern Time Registration Link: https:\/\/wsw.com\/webcast\/lifesci\/panel9\/2316951 \u00a0 \u00a0 Title: Executing a Successful Product Launch During a Pandemic Day: Friday, January 8 Time: 2:00pm Eastern Time Registration Link: https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307 The format will be a virtual presentation with the opportunity for Q&amp;A at the conclusion. About VYNE Therapeutics Inc. In March 2020, Menlo Therapeutics Inc. (&#8220;Menlo&#8221;) and Foamix Pharmaceuticals Ltd. (\u201cFoamix\u201d) combined to form &hellip; Continue reading \"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T13:03:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week","datePublished":"2021-01-05T13:03:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/"},"wordCount":351,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/","name":"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=","datePublished":"2021-01-05T13:03:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDUzNiMzOTA0NTM3IzIwOTM4MDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyne-therapeutics-to-present-at-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-this-week\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408369"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408369\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}